ranked for Strategy Consulting
Know when to call Eli Lilly and Company — before your competition does. kelvy agents monitor events in real time and surface ranked opportunities for Management Consulting firms.
Eli Lilly to acquire psychedelic company for $360 million
Eli Lilly has agreed to acquire a psychedelic drug developer from a billionaire founder in a deal valued at $360 million. The transaction involves the sale of the entire company, with the founder receiving the full proceeds.
Highlighted Opportunity
Post-Merger Integration (PMI)
Lilly must map the psychedelic unit's operations before the acquisition closes
A full acquisition of a founder-led company requires merging distinct R&D, culture, and operational processes; integration planning must begin now to avoid post-close disruption...
Track company & unlock full analysisWe'll prefill Strategy Consulting and this company so you land in a personal feed of ranked opportunities — not a blank account.
Public preview. Create an account to personalize scoring and digests.